Forschungsdatenbank PMU-SQQUID

Atorvastatin does not alter interferon Beta-induced changes of serum matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 in patients with multiple sclerosis.
Sellner, J; Greeve, I; Leib, SL; Mattle, HP;
Arch Neurol. 2008; 65(5):672-674
Letter

Abstract/Keywords Web of Science PubMed Full Text

PMU-Autor/inn/en

Sellner Johann

Useful keywords (using NLM MeSH Indexing)

Adjuvants, Immunologic/administration*

dosage

Adult

Atorvastatin Calcium

Biomarkers/analysis

Biomarkers/blood

Central Nervous System/drug effects

Central Nervous System/enzymology

Central Nervous System/physiopathology

Drug Interactions/immunology

Drug Therapy, Combination

Heptanoic Acids/administration*

dosage*

Heptanoic Acids/adverse effects

Humans

Hydroxymethylglutaryl-CoA Reductase Inhibitors/administration*

dosage

Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects

Immunologic Factors/administration*

dosage

Immunologic Factors/adverse effects

Interferon beta-1b

Interferon-beta/administration*

dosage*

Matrix Metalloproteinase 9/blood

Matrix Metalloproteinase 9/drug effects*

Multiple Sclerosis, Relapsing-Remitting/blood

Multiple Sclerosis, Relapsing-Remitting/drug therapy*

Multiple Sclerosis, Relapsing-Remitting/enzymology*

Pyrroles/administration*

dosage*

Pyrroles/adverse effects

Tissue Inhibitor of Metalloproteinase-1/blood

Tissue Inhibitor of Metalloproteinase-1/drug effects*

Treatment Outcome